Lilly Sues Generic Drugmakers To Protect Cymbalta

Tools

By Scott Sarvay

Story Published: Nov 18, 2008 at 5:14 PM EDT

Story Updated: Nov 18, 2008 at 5:14 PM EDT

INDIANAPOLIS (AP) - Eli Lilly and Co. has filed a federal suit
against four generic drugmakers to protect its patent for the
antidepressant drug Cymbalta.

The Indianapolis company sued Cobalt Laboratories, Impax
Laboratories, Sandoz and Wockhardt Ltd. after the companies filed
abbreviated new drug applications to make and sell a generic drug
before Lilly's patent expires in 2013.

Cymbalta is the brand name for the generic duloxetine
hydrochloride (doo-LOCKS'-uh-teen hy-droh-CLOR'-ide). It's Lilly's
second-best selling drug behind the anti-psychotic Zyprexa
(zy-PREX'-uh).

Lilly already has successfully defended the patent protecting
Zyprexa in federal court.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

What are your thoughts on this story? CLICK HERE to leave us "Your 2 Cents."


Add a comment

Name:

Comment: 1000 Characters Left

WISE INC TV NOW - and its affiliated companies are not responsible for the content of comments posted or for anything arising out of use of the above comments or other interaction among the users. We reserve the right to screen, refuse to post, remove or edit user-generated content at any time and for any or no reason in our absolute and sole discretion without prior notice, although we have no duty to do so or to monitor any Public Forum.

More Good Stuff

Advertisement

INC Weather

Icon
Current Temp 40.0 °F
Overcast
Wind : East at 17.3 MPH (15 KT)
Humidity : 73 %
Pressure : 1019.6 mb
More Weather

On Demand

Stock Quotes
This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

Poll

Vote for the 5 p.m. Fun Video:
Click Here